Some prescribers “titrate” patients to high “target” doses of cyclobenzaprine, duloxetine, gabapentin or pregabalin; and some guidelines advocate progressive dose increases.1-3 Whether intended to minimize adverse effects, or to improve pain relief, this approach is...
The UBC Innovation Support Unit in collaboration with the BC Centre on Substance Use and the Therapeutics Initiative presents: Think Twice! The (lack of) evidence for opioid analgesics to treat minor acute and chronic pain an educational...
Dr. Jessica Otte, MD, CCFP gave this presentation on October 17th, 2020 at the "Bringing Best Evidence to Clinicians" virtual conference. Dr. Otte is a family physician in Nanaimo, BC. She has always been passionate...
Case vignette: A 21 y/o has surgery for a condition expected to improve. He fills a discharge prescription for 5 days of an opioid at a standard dose. At 1-week follow-up with his family doctor...